Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Treatment of HBeAg-positive Chronic Hepatitis B With γδT Cells" Clinical Trial Protocol

NCT03113058 is registered in ClinicalTrials.gov with Jinan University Guangzhou as lead sponsor.

NCT NCT03113058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Treatment of HBeAg-positive Chronic Hepatitis B With γδT Cells" Clinical Trial Protocol
Lead sponsor
Jinan University Guangzhou
Phase
Phase 1
Overall status
Unknown status
Start date
May 2, 2017
Completion date
November 1, 2018
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adoptive treatment for hepatitis b with γδt cells